Ciglitazone

Caroline Day; Clifford J. Bailey

doi:10.1016/B978-008055232-3.61464-3

Ciglitazone

Caroline Day^*, Clifford J. Bailey

^*Corresponding author for this work

Research output: Chapter in Book/Published conference output › Chapter (peer-reviewed) › peer-review

Abstract

Ciglitazone was the first antidiabetic thiazolidinedione to be described in detail ....

Original language	English
Title of host publication	xPharm
Subtitle of host publication	the comprehensive pharmacology reference
Editors	S.J. Enna, David B. Bylund
Publisher	Elsevier
Number of pages	2
ISBN (Print)	978-0-08-055232-3
DOIs	https://doi.org/10.1016/B978-008055232-3.61464-3
Publication status	Published - Feb 2011

Access to Document

10.1016/B978-008055232-3.61464-3

Cite this

@inbook{6ed36c1150724f1b944aeba274718aa5,

title = "Ciglitazone",

abstract = "Ciglitazone was the first antidiabetic thiazolidinedione to be described in detail ....",

author = "Caroline Day and Bailey, {Clifford J.}",

year = "2011",

month = feb,

doi = "10.1016/B978-008055232-3.61464-3",

language = "English",

isbn = "978-0-08-055232-3",

editor = "S.J. Enna and Bylund, {David B.}",

booktitle = "xPharm",

publisher = "Elsevier",

address = "Netherlands",

}

TY - CHAP

T1 - Ciglitazone

AU - Day, Caroline

AU - Bailey, Clifford J.

PY - 2011/2

Y1 - 2011/2

N2 - Ciglitazone was the first antidiabetic thiazolidinedione to be described in detail ....

AB - Ciglitazone was the first antidiabetic thiazolidinedione to be described in detail ....

UR - http://www.scopus.com/inward/record.url?scp=84884102741&partnerID=8YFLogxK

U2 - 10.1016/B978-008055232-3.61464-3

DO - 10.1016/B978-008055232-3.61464-3

M3 - Chapter (peer-reviewed)

SN - 978-0-08-055232-3

BT - xPharm

A2 - Enna, S.J.

A2 - Bylund, David B.

PB - Elsevier

ER -

Ciglitazone

Abstract

Access to Document

Other files and links

Fingerprint

Biguanides

Metformin

Pioglitazone

Cite this